These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 8232098

  • 1. Pathogenesis of lipid abnormalities in patients with nephrotic syndrome/proteinuria: clinical implications.
    Warwick GL, Packard CJ.
    Miner Electrolyte Metab; 1993; 19(3):115-26. PubMed ID: 8232098
    [Abstract] [Full Text] [Related]

  • 2. Nephrotic hyperlipidemia: primary abnormalities in both lipoprotein catabolism and synthesis.
    Kaysen GA.
    Miner Electrolyte Metab; 1992; 18(2-5):212-6. PubMed ID: 1465061
    [Abstract] [Full Text] [Related]

  • 3. Proteinuria, hyperlipidemia, and the kidney.
    Hutchison FN.
    Miner Electrolyte Metab; 1993; 19(3):127-36. PubMed ID: 8232099
    [Abstract] [Full Text] [Related]

  • 4. [Disturbances of lipid metabolism during nephrotic syndrome: physiopathology and treatment].
    Moulin B, Ollier J, Olmer M.
    Nephrologie; 1992; 13(5):193-9. PubMed ID: 1470293
    [Abstract] [Full Text] [Related]

  • 5. Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statins.
    Wheeler DC.
    J Nephrol; 2001; 14 Suppl 4():S70-5. PubMed ID: 11798150
    [Abstract] [Full Text] [Related]

  • 6. Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory?
    Keane WF, St Peter JV, Kasiske BL.
    Kidney Int Suppl; 1992 Oct; 38():S134-41. PubMed ID: 1405364
    [Abstract] [Full Text] [Related]

  • 7. The causal role of hypoalbuminemia in human nephrotic hyperlipidemia.
    Rahman M, Salamatullah Q, Ferdous Z, Hussain MA.
    Bangladesh Med Res Counc Bull; 1976 Jun; 2(1):64-70. PubMed ID: 190998
    [Abstract] [Full Text] [Related]

  • 8. Lipids and progressive kidney disease.
    Moorhead JF.
    Kidney Int Suppl; 1991 Apr; 31():S35-40. PubMed ID: 2046269
    [Abstract] [Full Text] [Related]

  • 9. The hyperlipidemia of the nephrotic syndrome.
    Appel GB, Valeri A, Appel AS, Blum C.
    Am J Med; 1989 Nov; 87(5N):45N-50N. PubMed ID: 2486547
    [Abstract] [Full Text] [Related]

  • 10. Should hyperlipidemia in children with the nephrotic syndrome be treated?
    Querfeld U.
    Pediatr Nephrol; 1999 Jan; 13(1):77-84. PubMed ID: 10100296
    [Abstract] [Full Text] [Related]

  • 11. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
    Wanner C, Bartens W, Nauck M, Zäuner I, Greiber S, Schollmeyer P.
    Miner Electrolyte Metab; 1996 Jan; 22(1-3):26-30. PubMed ID: 8676820
    [Abstract] [Full Text] [Related]

  • 12. Adult nephrotic syndrome: non-specific strategies for treatment.
    Charlesworth JA, Gracey DM, Pussell BA.
    Nephrology (Carlton); 2008 Feb; 13(1):45-50. PubMed ID: 18199102
    [Abstract] [Full Text] [Related]

  • 13. [Plasma lipids in patients with chronic glomerulonephritis].
    Kolmakova EV.
    Urol Nefrol (Mosk); 1990 Feb; (1):16-9. PubMed ID: 2336751
    [Abstract] [Full Text] [Related]

  • 14. [Hyperlipoproteinemia in the nephrotic syndrome].
    Yasugi T, Shimizu T, Iijima M, Tomita M, Harada M.
    Saishin Igaku; 1972 Mar; 27(3):504-9. PubMed ID: 5021394
    [No Abstract] [Full Text] [Related]

  • 15. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P.
    Acta Med Croatica; 2001 Mar; 55(4-5):177-86. PubMed ID: 12398021
    [Abstract] [Full Text] [Related]

  • 16. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P, Reiner Z, Brunetta B.
    Lijec Vjesn; 2002 Mar; 124(11-12):372-7. PubMed ID: 12679979
    [Abstract] [Full Text] [Related]

  • 17. The effects of gemfibrozil on hyperlipidemia in children with persistent nephrotic syndrome.
    Büyükçelik M, Anarat A, Bayazit AK, Noyan A, Ozel A, Anarat R, Aydingülü H, Dikmen N.
    Turk J Pediatr; 2002 Mar; 44(1):40-4. PubMed ID: 11858378
    [Abstract] [Full Text] [Related]

  • 18. Lipid changes in the nephrotic syndrome: new insights into pathomechanisms and treatment.
    D'Amico G.
    Klin Wochenschr; 1991 Sep 03; 69(13):618-22. PubMed ID: 1753684
    [Abstract] [Full Text] [Related]

  • 19. [Lipid disturbances in the nephrotic syndrome].
    Chmielewski M, Zdrojewski Z, Rutkowski B.
    Przegl Lek; 2003 Sep 03; 60(11):758-61. PubMed ID: 15058052
    [Abstract] [Full Text] [Related]

  • 20. Hyperlipidaemia in untreated nephrotic syndrome, increased production or decreased removal?
    Chan MK, Persaud JW, Ramdial L, Varghese Z, Sweny P, Moorhead JF.
    Clin Chim Acta; 1981 Dec 24; 117(3):317-23. PubMed ID: 7318185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.